The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
Open accessAbstract
BACKGROUND: The growth and recurrence of several cancers appear to be driven by a population of cancer stem cells (CSCs). Glioblastoma, the most common primary brain tumor, is invariably fatal, with a median survival of approximately 1 year. Although experimental data have suggested the importance of CSCs, few data exist regarding the potential relevance and importance of these cells in a clinical setting. METHODS: We here present the first seven patients treated with a dendritic cell (DC)-based vaccine targeting CSCs in a solid tumor. Brain tumor biopsies were dissociated into single-cell suspensions, and autologous CSCs were expanded in vitro as tumorspheres. From these, CSC-mRNA was amplified and transfected into monocyte-derived autologous DCs. The DCs were aliquoted to 9-18 vaccines containing 10(7) cells each. These vaccines were injected intradermally at specified intervals after the patients had received a standard 6-week course of post-operative radio-chemotherapy. The study was registered with the ClinicalTrials.gov identifier NCT00846456. RESULTS: Autologous CSC cultures were established from ten out of eleven tumors. High-quality RNA was isolated, and mRNA was amplified in all cases. Seven patients were able to be weaned from corticosteroids to receive DC immunotherapy. An immune response induced by vaccination was identified in all seven patients. No patients developed adverse autoimmune events or other side effects. Compared to matched controls, progression-free survival was 2.9 times longer in vaccinated patients (median 694 vs. 236 days, p = 0.0018, log-rank test). CONCLUSION: These findings suggest that vaccination against glioblastoma stem cells is safe, well-tolerated, and may prolong progression-free survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Reynolds, B. A., & Weiss, S. (1992) · Science · doi:10.1126/science.1553558 · Cited by 4,482
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., & Vescovi, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
Efficient tumour formation by single human melanoma cells
Quintana, E., Shackleton, M., Sabel, M. S., Fullen, D. R., Johnson, T. M., & Morrison, S. J. (2008) · Nature · doi:10.1038/nature07567 · Cited by 1,796
Stem cell gene expression programs influence clinical outcome in human leukemia
Eppert, K., Takenaka, K., Lechman, E. R., Waldron, L., Nilsson, B., van Galen, P., Metzeler, K. H., Poeppl, A., Ling, V., Beyene, J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2415 · Cited by 1,041
Ignatova, T. N., Kukekov, V. G., Laywell, E. D., Suslov, O. N., Vrionis, F. D., & Steindler, D. A. (2002) · Glia · doi:10.1002/glia.10094 · Cited by 992
Cancer stem cells in nervous system tumors
Singh, S. K., Clarke, I. D., Hide, T., & Dirks, P. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207946 · Cited by 569
A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma
Chen, R., Nishimura, M. C., Bumbaca, S. M., Kharbanda, S., Forrest, W. F., Kasman, I. M., Greve, J. M., Soriano, R. H., Gilmour, L. L., Rivers, C. S., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.049 · Cited by 544
Isolation and Characterization of a Stem Cell Population from Adult Human Liver
Herrera, M. B., Bruno, S., Buttiglieri, S., Tetta, C., Gatti, S., Deregibus, M. C., Bussolati, B., & Camussi, G. (2006) · STEM CELLS · doi:10.1634/stemcells.2006-0114 · Cited by 413
Gentles, A. J. (2010) · JAMA · doi:10.1001/jama.2010.1862 · Cited by 395
The developing cancer stem-cell model: clinical challenges and opportunities
Vermeulen, L., de Sousa e Melo, F., Richel, D. J., & Medema, J. P. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70257-1 · Cited by 393
Phuphanich, S., Wheeler, C. J., Rudnick, J. D., Mazer, M., Wang, H., Nuño, M. A., Richardson, J. E., Fan, X., Ji, J., Chu, R. M., et al. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1319-0 · Cited by 388
Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme
Pallini, R., Ricci-Vitiani, L., Banna, G. L., Signore, M., Lombardi, D., Todaro, M., Stassi, G., Martini, M., Maira, G., Larocca, L. M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0644 · Cited by 355
Boczkowski, D., Nair, S. K., Nam, J., Lyerly, H. K., & Gilboa, E. (2000) · PubMed · Cited by 313
CD133 as a Marker for Cancer Stem Cells: Progresses and Concerns
Wu, Y., & Wu, P. Y. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0338 · Cited by 293
Lottaz, C., Beier, D., Meyer, K., Kumar, P., Hermann, A., Schwarz, J., Junker, M., Oefner, P. J., Bogdahn, U., Wischhusen, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1707 · Cited by 272
Salmaggi, A., Boiardi, A., Gelati, M., Russo, A., Calatozzolo, C., Ciusani, E., Sciacca, F. L., Ottolina, A., Parati, E. A., La Porta, C., et al. (2006) · Glia · doi:10.1002/glia.20414 · Cited by 254
Pellegatta, S., Poliani, P. L., Corno, D., Menghi, F., Ghielmetti, F., Suarez-Merino, B., Caldera, V., Nava, S., Ravanini, M., Facchetti, F., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2048 · Cited by 248
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
Wakimoto, H., Mohapatra, G., Kanai, R., Curry, W. T., Yip, S., Nitta, M., Patel, A. P., Barnard, Z. R., Stemmer-Rachamimov, A. O., Louis, D. N., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nor195 · Cited by 244
Neurosphere Formation Is an Independent Predictor of Clinical Outcome in Malignant Glioma
Laks, D. R., Masterman-Smith, M., Visnyei, K., Angenieux, B., Orozco, N. M., Foran, I., Yong, W. H., Vinters, H. V., Liau, L. M., Lazareff, J. A., et al. (2009) · Stem Cells · doi:10.1002/stem.15 · Cited by 238
Xu, Q., Liu, G., Yuan, X., Xu, M., Wang, H., Ji, J., Konda, B., Black, K. L., & Yu, J. S. (2009) · Stem Cells · doi:10.1002/stem.102 · Cited by 217
Helseth, R., Helseth, E., Johannesen, T. B., Langberg, C. W., Lote, K., Rønning, P., Scheie, D., Vik, A., & Meling, T. R. (2010) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2010.01350.x · Cited by 215
Self-citationPhase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNA
Kyte, J. A., Mu, L., Aamdal, S., Kvalheim, G., Dueland, S., Hauser, M., Gullestad, H. P., Ryder, T., Lislerud, K., Hammerstad, H., et al. (2006) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700961 · Cited by 212
Self-citationArdon, H., Van Gool, S. W., Verschuere, T., Maes, W., Fieuws, S., Sciot, R., Wilms, G., Demaerel, P., Goffin, J., Van Calenbergh, F., et al. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1261-1 · Cited by 165
Sæbøe‐Larssen, S., Fossberg, E., & Gaudernack, G. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00506-3 · Cited by 151
Self-citationRecognition and Killing of Brain Tumor Stem-Like Initiating Cells by CD8+ Cytolytic T Cells
Brown, C. E., Starr, R., Martínez, C., Aguilar, B., D’Apuzzo, M., Todorov, I., Shih, C.-C., Badie, B., Hudecek, M., Riddell, S. R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2687 · Cited by 137
Mu, L., Kyte, J. A., Kvalheim, G., Aamdal, S., Dueland, S., Hauser, M., Hammerstad, H., Wæhre, H., Raabe, N. K., & Gaudernack, G. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602761 · Cited by 115
Self-citationKyte, J. A., Gaudernack, G., Dueland, S., Trachsel, S., Julsrud, L., & Aamdal, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0184 · Cited by 111
Self-citationMoe, M. C., Varghese, M., Danilov, A. I., Westerlund, U., Ramm‐Pettersen, J., Brundin, L., Svensson, M. A., Berg–Johnsen, J., & Langmoen, I. A. (2005) · Brain · doi:10.1093/brain/awh574 · Cited by 110
Self-citationConcomitant regulation of T-cell activation and homeostasis
Grossman, Z., Min, B., Meier‐Schellersheim, M., & Paul, W. E. (2004) · Nature reviews. Immunology · doi:10.1038/nri1355 · Cited by 109
Inderberg, E. M., Dueland, S., Rasmussen, A., Vetrhus, T., Aamdal, S., Kvalheim, G., & Gaudernack, G. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-0991-9 · Cited by 93
Self-citationDeleyrolle, L. P., Ericksson, G., Morrison, B. J., López, J. A., Burrage, K., Burrage, P., Vescovi, A. L., Rietze, R. L., & Reynolds, B. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015844 · Cited by 93
Takamiya, M., Haider, K. H., & Ashraf, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025265 · Cited by 91
Gliosarcoma Stem Cells Undergo Glial and Mesenchymal Differentiation In Vivo
deCarvalho, A. C., Nelson, K. K., Lemke, N. W., Lehman, N. L., Arbab, A. S., Kalkanis, S. N., & Mikkelsen, T. (2009) · Stem Cells · doi:10.1002/stem.264 · Cited by 73
Vik-Mo, E. O., Sandberg, C. J., Ølstørn, H., Varghese, M., Brandal, P., Ramm‐Pettersen, J., Murrell, W. G., & Langmoen, I. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq102 · Cited by 63
Self-citationKyte, J. A., Kvalheim, G., Aamdal, S., Sæbøe‐Larssen, S., & Gaudernack, G. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700837 · Cited by 61
Self-citationDepletion of T lymphocytes is correlated with response to temozolomide in melanoma patients
Iversen, T. Z., Brimnes, M. K., Nikolajsen, K., Andersen, R. S., Hadrup, S. R., Andersen, M. H., Bastholt, L., & Svane, I. M. (2013) · OncoImmunology · doi:10.4161/onci.23288 · Cited by 32
Vik-Mo, E. O., Sandberg, C. J., Joel, M., Stangeland, B., Watanabe, Y., Mackay‐Sim, A., Moe, M. C., Murrell, W. G., & Langmoen, I. A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.12.022 · Cited by 27
Self-citation(2003) · PubMed
Cited by
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Current state of immunotherapy for glioblastoma
Lim, M., Xia, Y., Bettegowda, C., & Weller, M. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0003-5 · Cited by 1,365
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 771
Immunotherapy for glioma: Current management and future application
Xu, S., Tang, L., Li, X., Fan, F., & Liu, Z. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.002 · Cited by 746
Glioma targeted therapy: insight into future of molecular approaches
Yang, K., Wu, Z., Zhang, H., Zhang, N., Wu, W., Wang, Z., Dai, Z., Zhang, X., Zhang, L., Peng, Y., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01513-z · Cited by 704
Metadata
- Authors
- Vik-Mo, E. O., Nyakas, M., Mikkelsen, B. V., Moe, M. C., Due-Tønnesen, P., Suso, E. M. I., Sæbøe-Larssen, S., Sandberg, C., Brinchmann, J. E., Helseth, E., Rasmussen, A.-M., Lote, K., Aamdal, S., Gaudernack, G., Kvalheim, G., & Langmoen, I. A.
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2013-07-02
- Volume
- 62
- Issue
- 9
- Pages
- 1499-1509
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- OpenAlex
- W2100004531
- Cited by
- 315
- References
- 43
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.